Bonus BioGroup Balance Sheet Health

Financial Health criteria checks 4/6

Bonus BioGroup has a total shareholder equity of ₪15.4M and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪32.0M and ₪16.6M respectively.

Key information

0%

Debt to equity ratio

₪0

Debt

Interest coverage ration/a
Cash₪14.14m
Equity₪15.40m
Total liabilities₪16.62m
Total assets₪32.02m

Recent financial health updates

Financial Position Analysis

Short Term Liabilities: BONS's short term assets (₪14.6M) exceed its short term liabilities (₪7.5M).

Long Term Liabilities: BONS's short term assets (₪14.6M) exceed its long term liabilities (₪9.1M).


Debt to Equity History and Analysis

Debt Level: BONS is debt free.

Reducing Debt: BONS had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BONS has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: BONS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.4% each year


Discover healthy companies